$ADPT Adaptive Biotechnologies Corp Insider Trading Week 14/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp in week 14/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | ADPT | Adaptive Biotechno ... | ADAMS R MARK | Chief Operating Off ... | Sell | S | 42.34 | 3,586 | 151,831 | 67,018 | 70.6 K to 67 K (-5.08 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 25,000 | |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 35,000 | |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 42.34 | 806 | 34,126 | 21,604 | 22.4 K to 21.6 K (-3.60 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 41.59 | 9,194 | 382,378 | 22,410 | 31.6 K to 22.4 K (-29.09 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.95 | 10,000 | 409,500 | 21,604 | 31.6 K to 21.6 K (-31.64 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.78 | 100 | 4,378 | 1,748,461 | 1.7 M to 1.7 M (-0.01 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.00 | 1,957 | 84,151 | 1,748,561 | 1.8 M to 1.7 M (-0.11 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.04 | 2,943 | 123,724 | 1,750,518 | 1.8 M to 1.8 M (-0.17 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.45 | 1,100 | 45,595 | 1,753,461 | 1.8 M to 1.8 M (-0.06 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.61 | 3,900 | 158,379 | 1,754,561 | 1.8 M to 1.8 M (-0.22 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.08 | 1,200 | 51,696 | 1,758,461 | 1.8 M to 1.8 M (-0.07 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.48 | 2,200 | 93,456 | 1,759,661 | 1.8 M to 1.8 M (-0.12 %) |
Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.08 | 1,600 | 65,728 | 1,761,861 | 1.8 M to 1.8 M (-0.09 %) |